- Home
- CGEN
CGEN
Compugen Ltd.
as 03-25-2025 3:30pm EST
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
| Founded: | 1993 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 149.6M | IPO Year: | 2000 |
| Target Price: | $4.00 | AVG Volume (30 days): | 299.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.35 - $2.66 | Next Earning Date: | 03-04-2025 |
| Revenue: | $27,864,000 | Revenue Growth: | -16.72% |
| Revenue Growth (this year): | 22.94% | Revenue Growth (next year): | 15.88% |
Latest Compugen Ltd. News
CGEN Breaking Stock News: Dive into CGEN Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts
Simply Wall St.
19 days ago
Calculating The Intrinsic Value Of Compugen Ltd. (NASDAQ:CGEN)
GuruFocus.com
21 days ago
Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Zacks
21 days ago
Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates
Associated Press Finance
21 days ago
Compugen: Q4 Earnings Snapshot
PR Newswire
21 days ago
/C O R R E C T I O N -- Compugen Ltd./
PR Newswire
22 days ago
Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference
PR Newswire
a month ago
Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics' Single Cell Genomics Sequencing Technology
Compare CGEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CGEN Compugen Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.